Image

Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes

Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to learn if knowing risk for diabetes can help adult patients with prediabetes take steps to get care and prevent diabetes. The main questions it aims to answer are:

  • Does a shared-decision making visit with a health care team member to talk about the participant's diabetes risk increase participants' taking steps to prevent diabetes?
  • Does a simple message in the patient portal about the participant's diabetes risk increase participants' taking steps to prevent diabetes?

Researchers will compare the visit with usual care at the clinic to see if the visit increases participants' taking steps to prevent diabetes. Separately, the researchers will compare the patient message with usual care at the clinic to see if the message increases participants' taking steps to prevent diabetes.

Participants will:

  • Complete surveys at the beginning of the study and up to 2 additional surveys
  • If the participant falls into the shared decision-making group, the participant will have one 30-minute visit with a healthcare team member to talk about risk of diabetes and how to lower it.

Eligibility

Inclusion Criteria:

  • prediabetes based on most recent HbA1c (5.7-6.4%) or fasting plasma glucose (100-125 mg/dL) in prior 12 months
  • active patient portal account (MyChart)
  • patient receiving primary care at Johns Hopkins Community Physicians in Frederick
  • have overweight or obesity (BMI ≥ 25 kg/m2)

Exclusion Criteria:

  • have diabetes (HbA1c \> 6.4% in prior 6 months or on diabetes registry)
  • have dementia
  • previously participated in the Diabetes Prevention Program (DPP)

Study details
    Prediabetes
    Prediabetes (Insulin Resistance
    Impaired Glucose Tolerance)

NCT07553325

Johns Hopkins University

29 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.